Itraconazole and fluconazole in oropharyngeal candidiasis.
Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis. The pharmacology of these two drugs and their use in clinical studies are discussed in this review.
van der Bijl
P
P
Department of Oral Medicine and Periodontics, Faculty of Dentistry, University of Stellenbosch.
Arendorf
T M
TM
D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000188:drug therapy*; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use*; D010608:Pharyngeal Diseases / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole; D007654:Ketoconazole